C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population: Edinburgh Artery Study

Background—The relationship between levels of circulating inflammatory markers and risk of progressive atherosclerosis is relatively undetermined. We therefore studied inflammatory markers as predictors of peripheral atherosclerotic progression, measured by the ankle-brachial index (ABI) at 3 consecutive time points over 12 years. Methods and Results—The Edinburgh Artery Study is a population cohort study of 1592 men and women aged 55 to 74 years. C-reactive protein (CRP), interleukin-6 (IL-6), intercellular adhesion molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1), and E-selectin were measured at baseline. Valid ABI measurements were obtained on 1582, 1081, and 813 participants at baseline and 5-year and 12-year follow-up examinations, respectively. At baseline, a significant trend was found between higher plasma levels of CRP (P≤0.05) and increasing severity of peripheral arterial disease (PAD), after adjustment for baseline cardiovascular risk factors. IL-6 at baseline (P≤0.001) was associated with progressive atherosclerosis at 5 years (ABI change from baseline), and CRP (P≤0.01), IL-6 (P≤0.001), and ICAM-1 (P≤0.01) were associated with changes at 12 years, independently of baseline ABI, cardiovascular risk factors, and baseline cardiovascular disease. Only IL-6 independently predicted ABI change at 5 years (P≤0.01) and 12 years (P≤0.05) in analyses of all inflammatory markers simultaneously and adjusted for baseline ABI, cardiovascular risk factors, and cardiovascular disease at baseline. Conclusions—These findings suggest that CRP, IL-6, and ICAM-1 are molecular markers associated with atherosclerosis and its progression. IL-6 showed more consistent results and stronger independent predictive value than other inflammatory markers.

[1]  D. Stirling,et al.  Interleukin 6 and Haemostasis , 2001, British journal of haematology.

[2]  C. McCollum,et al.  Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease. , 2000, Thrombosis research.

[3]  R. Langer,et al.  Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing , 1999, Vascular medicine.

[4]  A. Blann,et al.  Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease , 1997, European journal of clinical investigation.

[5]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[6]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[7]  S. Rubin,et al.  Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). , 2003, The American journal of cardiology.

[8]  Ronald J. Prineas,et al.  The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification , 1982 .

[9]  A. Blann,et al.  Circulating ICAM-1 and VCAM-1 in Peripheral Artery Disease and Hypercholesterolaemia: Relationship to the Location of Atherosclerotic Disease, Smoking, and in the Prediction of Adverse Events , 1998, Thrombosis and Haemostasis.

[10]  G. A. Rose.  The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. , 1962, Bulletin of the World Health Organization.

[11]  L. Kuller,et al.  Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.

[12]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[13]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[14]  R. de Caterina,et al.  Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[15]  L. Lind.  Circulating markers of inflammation and atherosclerosis. , 2003, Atherosclerosis.

[16]  B. Fagerberg,et al.  Circulating ICAM-1 (intercellular cell-adhesion molecule 1) is associated with early stages of atherosclerosis development and with inflammatory cytokines in healthy 58-year-old men: the Atherosclerosis and Insulin Resistance (AIR) study. , 2002, Clinical science.

[17]  G. Malaponte,et al.  High circulating levels of cytokines (IL-6 and TNFa), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test , 2003, Vascular medicine.

[18]  G. Lowe,et al.  Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[19]  P. Ridker,et al.  Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. , 2003, The American journal of cardiology.

[20]  C. Fisher,et al.  Variation in measurement of ankle-brachial pressure index in routine clinical practice. , 1996, Journal of vascular surgery.

[21]  R J Prineas,et al.  International diagnostic criteria for acute myocardial infarction and acute stroke. , 1984, American heart journal.

[22]  J. Danesh,et al.  Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis , 2001, The Lancet.

[23]  N. Fiotti,et al.  Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. , 1999, Atherosclerosis.

[24]  D. Levy,et al.  Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[25]  C. Bode,et al.  Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[26]  R. Depalma,et al.  Cytokine signatures in atherosclerotic claudicants. , 2003, The Journal of surgical research.

[27]  M. Chiariello,et al.  Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis , 2003, Thrombosis and Haemostasis.

[28]  Diane Catellier,et al.  C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. , 2002, American heart journal.

[29]  A. Hofman,et al.  C-Reactive Protein Predicts Progression of Atherosclerosis Measured at Various Sites in the Arterial Tree: The Rotterdam Study , 2002, Stroke.

[30]  W. Sheu,et al.  C‐reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[31]  A. Blann,et al.  Circulating Endothelial Cell/Leukocyte Adhesion Molecules in Atherosclerosis , 1994, Thrombosis and Haemostasis.

[32]  P. Ridker,et al.  Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. , 1998, Circulation.

[33]  R. Prescott,et al.  Variability of ankle and brachial systolic pressures in the measurement of atherosclerotic peripheral arterial disease. , 1988, Journal of epidemiology and community health.

[34]  P. Ridker,et al.  Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men , 2002, Circulation.

[35]  S. Blankenberg,et al.  Adhesion molecules and atherosclerosis. , 2003, Atherosclerosis.

[36]  J. Pankow,et al.  Association of C-reactive protein with markers of prevalent atherosclerotic disease. , 2001, The American journal of cardiology.

[37]  H. Becher,et al.  The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. , 1996, Thrombosis research.

[38]  P. Ridker,et al.  Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. , 2000, Journal of the American College of Cardiology.

[39]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[40]  W. Haefeli,et al.  Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. , 1999, Atherosclerosis.

[41]  K. Shyu,et al.  Circulating intercellular adhesion molecule-1 and E-selectin in patients with acute coronary syndrome. , 1996, Chest.

[42]  O. Wagner,et al.  Joint Effects of C-Reactive Protein and Glycated Hemoglobin in Predicting Future Cardiovascular Events of Patients With Advanced Atherosclerosis , 2003, Circulation.

[43]  P. Ridker,et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.

[44]  T. V. van Berkel,et al.  Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential , 2003, Pharmacological Reviews.

[45]  N Rifai,et al.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.

[46]  P. Donnan,et al.  Physical activity and risk of peripheral arterial disease in the general population: Edinburgh Artery Study. , 1993, Journal of epidemiology and community health.

[47]  Janet B. Dunbar,et al.  Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. , 1996, International journal of epidemiology.

[48]  R. Prescott,et al.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. , 1991, International journal of epidemiology.

[49]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[50]  Y. Aso,et al.  Results of blood inflammatory markers are associated more strongly with toe-brachial index than with ankle-brachial index in patients with type 2 diabetes. , 2004, Diabetes care.

[51]  A. Hofman,et al.  Inflammatory Mediators and Cell Adhesion Molecules as Indicators of Severity of Atherosclerosis: The Rotterdam Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.